Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: Genetic and epigenetic modifications induced by chemotherapeutic drugs: human amniotic fluid stem cells as an in-vitro model

Fig. 2

Expression of a Pluripotency markers SOX2, Oct4, NANOG, KLF4, c-Myc and C-Kit and b Germline markers (Stella, fragilis, VASA, DAZL, STRA8, PIWIL2, BOLL and SYCP3) in treated cells with respect to control. The expressions were compared with control, normalizing control expression as 1. *p < 0.05, **p < 0.01, *** p < 0.001 and ****p < 0.0001

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us